Center-Authored Papers

Filters: Author is Juco, Jonathan  [Clear All Filters]
Journal Article
Yearley JH, Gibson C, Yu N, Moon C, Murphy E, Juco J, Lunceford J, Cheng J, Chow LQM, Seiwert TY et al..  2017.  PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(12):3158-3167. Abstract
Muro K, Chung HC, Shankaran V, Geva R, Catenacci D, Gupta S, Eder JP, Golan T, Le DT, Burtness B et al..  2016.  Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.. The Lancet. Oncology. Abstract
Plimack ER, Bellmunt J, Gupta S, Berger R, Chow LQM, Juco J, Lunceford J, Saraf S, Perini RF, O'Donnell PH.  2017.  Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.. The Lancet. Oncology. Abstract